OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Showing 1-25 of 73 citing articles:
Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases
Yuming Sun, Qian Zhou, Lorraine Edna Onzere, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025) Vol. 19, Iss. 1, pp. 103186-103186
Closed Access | Times Cited: 3
Yuming Sun, Qian Zhou, Lorraine Edna Onzere, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025) Vol. 19, Iss. 1, pp. 103186-103186
Closed Access | Times Cited: 3
Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs
Xing Wan, Jingyuan Ma, He Bai, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 140-140
Open Access | Times Cited: 2
Xing Wan, Jingyuan Ma, He Bai, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 140-140
Open Access | Times Cited: 2
Glucagon like peptide-1 receptor agonists as a promising therapeutic option of metabolic dysfunction associated steatotic liver disease and obesity: hitting two targets with one shot
Eda Kaya, Wing‐Kin Syn, Paul Manka
Current Opinion in Gastroenterology (2025)
Closed Access | Times Cited: 2
Eda Kaya, Wing‐Kin Syn, Paul Manka
Current Opinion in Gastroenterology (2025)
Closed Access | Times Cited: 2
Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence
Lívia Cristina Ribeiro Teixeira, Marcelo R. Luizon, Karina Braga Gomes
Receptors (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
Lívia Cristina Ribeiro Teixeira, Marcelo R. Luizon, Karina Braga Gomes
Receptors (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
G-Protein-Coupled Receptor (GPCR) Signaling and Pharmacology in Metabolism: Physiology, Mechanisms, and Therapeutic Potential
Y. Cho, Soyeon Kim, Pan-Kyung Kim, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 291-291
Open Access | Times Cited: 1
Y. Cho, Soyeon Kim, Pan-Kyung Kim, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 291-291
Open Access | Times Cited: 1
Risk of Glaucoma in Non-Diabetic Patients using a Glucagon Like Peptide-1 Receptor Agonist
Pranav Vasu, Emily Dorairaj, Robert N. Weinreb, et al.
Ophthalmology (2025)
Closed Access | Times Cited: 1
Pranav Vasu, Emily Dorairaj, Robert N. Weinreb, et al.
Ophthalmology (2025)
Closed Access | Times Cited: 1
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Dysregulation of Metabolic Peptides in the Gut–Brain Axis Promotes Hyperinsulinemia, Obesity, and Neurodegeneration
Camille Green, Vandana Zaman, Kayce Blumenstock, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 132-132
Open Access
Camille Green, Vandana Zaman, Kayce Blumenstock, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 132-132
Open Access
Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward
David Toro-Tobón, Naykky Singh Ospina, Juan P. Brito
Thyroid (2025)
Closed Access
David Toro-Tobón, Naykky Singh Ospina, Juan P. Brito
Thyroid (2025)
Closed Access
Pre-Type 1 Diabetes in Adolescents and Teens: Screening, Nutritional Interventions, Beta-Cell Preservation, and Psychosocial Impacts
Brody Sundheim, Krish Hirani, M Blaschke, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 383-383
Open Access
Brody Sundheim, Krish Hirani, M Blaschke, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 383-383
Open Access
Recent Advances in Promoting Bone Regeneration in Type 2 Diabetes Using Drug Delivery Vehicles and Vehicle‐Free Therapeutics
Yasamin Pesaran Afsharian, Mostafa Rahimnejad, Sayed Mahmood Rabiee, et al.
Advanced Therapeutics (2025)
Closed Access
Yasamin Pesaran Afsharian, Mostafa Rahimnejad, Sayed Mahmood Rabiee, et al.
Advanced Therapeutics (2025)
Closed Access
ACUTE HYPERGLYCEMIA INDUCES PODOCYTE APOPTOSIS BY MONOCYTE TNF-α RELEASE, A PROCESS ATTENUATED BY VITAMIN D AND GLP-1 RECEPTOR AGONISTS
Rong M. Zhang, Jisu Oh, Burton M. Wice, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2025), pp. 106676-106676
Closed Access
Rong M. Zhang, Jisu Oh, Burton M. Wice, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2025), pp. 106676-106676
Closed Access
Discovery of Selenium-Containing Derivatives as Potent and Orally Bioavailable GLP-1R Agonists
Xuetao Chen, Shicheng Xu, Shuang Yang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Xuetao Chen, Shicheng Xu, Shuang Yang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Vagotomy suppresses food intake by increasing GLP-1 secretion via the M3 AChR-AMPKα pathway in mice
Jie Lin, Yikai Shen, Yiwen Xia, et al.
Molecular and Cellular Endocrinology (2025), pp. 112464-112464
Closed Access
Jie Lin, Yikai Shen, Yiwen Xia, et al.
Molecular and Cellular Endocrinology (2025), pp. 112464-112464
Closed Access
The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders: a systematic review and meta-analysis
Hanieh Radkhah, Shiva Rahimipour Anaraki, Peyvand Parhizkar Roudsari, et al.
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2025) Vol. 30, Iss. 1
Open Access
Hanieh Radkhah, Shiva Rahimipour Anaraki, Peyvand Parhizkar Roudsari, et al.
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2025) Vol. 30, Iss. 1
Open Access
Ozempic v Mounjaro: what is the difference between semaglutide and tirzepatide?
Katharine Lang
BMJ (2025), pp. q2636-q2636
Closed Access
Katharine Lang
BMJ (2025), pp. q2636-q2636
Closed Access
A 2-Years Comparative Analysis of Tirzepatide, Semaglutide, Qsymia, Contrave, and Phentermine on Ocular Health in Individuals with Obesity: A Propensity-Score Matched Cohort Study
Pen‐Hua Su, Yu‐Nan Huang, Jo-Ching Chen, et al.
Research Square (Research Square) (2025)
Closed Access
Pen‐Hua Su, Yu‐Nan Huang, Jo-Ching Chen, et al.
Research Square (Research Square) (2025)
Closed Access
Improved glucose handling in female rat offspring of a hypertensive pregnancy with intrauterine growth restriction
Melissa A. Cedars, Kate M. Root, Brian Akhaphong, et al.
Physiological Reports (2025) Vol. 13, Iss. 3
Open Access
Melissa A. Cedars, Kate M. Root, Brian Akhaphong, et al.
Physiological Reports (2025) Vol. 13, Iss. 3
Open Access
Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis
Georgiana-Diana Cazac, C.M. Lǎcǎtusu, Elena-Daniela Grigorescu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1042-1042
Open Access
Georgiana-Diana Cazac, C.M. Lǎcǎtusu, Elena-Daniela Grigorescu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1042-1042
Open Access
Glucagon-like peptide-1 receptor agonism and end-organ protection
Samuel J. Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
Samuel J. Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
GLP-1 Agonists in Type 1 Diabetes – Indications and Use
Panadeekarn Panjawatanan, Richard J. Comi
Obesity Medicine (2025), pp. 100591-100591
Closed Access
Panadeekarn Panjawatanan, Richard J. Comi
Obesity Medicine (2025), pp. 100591-100591
Closed Access
Is this the end of obesity?
Mark Greener
Independent Nurse (2025) Vol. 2025, Iss. 2, pp. 8-10
Closed Access
Mark Greener
Independent Nurse (2025) Vol. 2025, Iss. 2, pp. 8-10
Closed Access
Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults
Marco Infante, F Silvestri, Nathalia Padilla, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1303-1303
Open Access
Marco Infante, F Silvestri, Nathalia Padilla, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1303-1303
Open Access
Association Between GLP1 RAs Use and Risk of Colorectal Cancer: A Systematic Review and Meta‐Analysis
Ganesh Bushi, Shilpa Gaidhane, Suhas Ballal, et al.
Health Science Reports (2025) Vol. 8, Iss. 2
Open Access
Ganesh Bushi, Shilpa Gaidhane, Suhas Ballal, et al.
Health Science Reports (2025) Vol. 8, Iss. 2
Open Access
Regulation of GLP-1 and Glucagon Receptor Function by β-Arrestins in Metabolically Important Cell Types
Liu Liu, Muhammad Rashid, Jürgen Wess
Biochemistry (2025)
Closed Access
Liu Liu, Muhammad Rashid, Jürgen Wess
Biochemistry (2025)
Closed Access
